Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications

Michail Papadourakis, Evangelia Efraimia Amaxopoulou, Minos-Timotheos Matsoukas

Open source

DOI
10.1080/17460441.2026.2712551
Published
2026-08-07
Container
Expert Opinion on Drug Discovery
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17460441.2026.2712551,
  title = {Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications},
  author = {Michail Papadourakis and Evangelia Efraimia Amaxopoulou and Minos-Timotheos Matsoukas},
  year = {2026},
  journal = {Expert Opinion on Drug Discovery},
  doi = {10.1080/17460441.2026.2712551},
  url = {https://doi.org/10.1080/17460441.2026.2712551}
}

RIS

TY  - JOUR
TI  - Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications
AU  - Michail Papadourakis
AU  - Evangelia Efraimia Amaxopoulou
AU  - Minos-Timotheos Matsoukas
PY  - 2026
JO  - Expert Opinion on Drug Discovery
DO  - 10.1080/17460441.2026.2712551
UR  - https://doi.org/10.1080/17460441.2026.2712551
ER  - 

APA

Papadourakis, M., Amaxopoulou, E. E., & Matsoukas, M. (2026). Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications. Expert Opinion on Drug Discovery. https://doi.org/10.1080/17460441.2026.2712551

Source records